<DOC>
	<DOCNO>NCT01631227</DOCNO>
	<brief_summary>Aim study compare blood pressure lower effect new drug formulation eprosartan . Eprosartan belong class blood pressure lower agent use worldwide since year proven efficacy . The new formulation compare currently market eprosartan tablet . Equivalent efficacy blood pressure lower effect demonstrate .</brief_summary>
	<brief_title>Comparison Effect Eprosartan Eprosartan Mesylate Blood Pressure Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eprosartan</mesh_term>
	<criteria>Inclusion Criteria Males females essential hypertension , blood pressure value 140 mmHg 179 mmHg systolic 90 mmHg 109 mmHg diastolic Given write informed consent prior start study Exclusion Criteria Women childbearing potential , breast feeding pregnant ; Inability discontinue prior antihypertensive medication ; Secondary hypertension Severe hypertension Severe diabetes mellitus ( HbA1c great 8.5 % )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>